Barchart on MSN
Oracle Stock Slides 36%. Should You Buy, Sell, or Hold ORCL?
Oracle (ORCL) stock has taken a sharp turn after an impressive run, sliding more than 36% from its peak of $345.72. The ...
A majority of early users say Oracle Health’s new Clinical AI Agent is reducing documentation time and easing clinician burnout, according to a Nov. 12 KLAS Research report. KLAS interviewed 17 ...
Oracle's stock has fallen more than 30% from its peak. Oracle Corp.'s stock can reclaim its highs and then post even bigger gains from there, according to a Jefferies analyst.
Oracle ( ORCL +2.43%) is expected to report its second-quarter fiscal 2026 earnings on Dec. 8. It's a tough encore to the ...
TipRanks on MSN
Moderately bullish activity in Oracle with shares up 2.42%
Moderately bullish activity in Oracle (ORCL), with shares up $5.26, or 2.42%, near $222.83. Options volume more than double the daily average with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results